I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
The value of 4D body-to-whole dynamic acquisition in FDG PET / CT to differentiate progression / pseudo-progression during the first therapeutic assessment (PET1) of metastatic melanoma treated with immune checkpoint inhibitors (ICI)to predict the progression of the disease..
metastatic melanoma
pembrolizumab
nivolumab
melanoma
dynamic acquisition
- 0 views
- 16 Feb, 2024
- 1 location